This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2002 Mar;109(3):572-3.

doi: 10.1067/mai.2002.121700.

Myocardial ischemia possibly mediated by cysteinyl leukotrienes

Andrew Szczeklik, Ewa Nizankowska, Lucyna Mastalerz, Grazyna Bochenek

PMID: 11898009
DOI: 10.1067/mai.2002.121700

Case Reports

Myocardial ischemia possibly mediated by cysteinyl leukotrienes

Andrew Szczeklik et al. J Allergy Clin Immunol. 2002 Mar.

. 2002 Mar;109(3):572-3.

doi: 10.1067/mai.2002.121700.

Authors

Andrew Szczeklik, Ewa Nizankowska, Lucyna Mastalerz, Grazyna Bochenek

PMID: 11898009
DOI: 10.1067/mai.2002.121700

No abstract available

PubMed Disclaimer

Similar articles

Endothelial cysteinyl leukotriene 2 receptor expression and myocardial ischemia/reperfusion injury.
Moos MP, Funk CD. Moos MP, et al. Trends Cardiovasc Med. 2008 Oct;18(7):268-73. doi: 10.1016/j.tcm.2008.11.009. Trends Cardiovasc Med. 2008. PMID: 19232956 Review.
Binding to cysteinyl-leukotriene receptors.
Nicosia S, Capra V, Ravasi S, Rovati GE. Nicosia S, et al. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S46-50. doi: 10.1164/ajrccm.161.supplement_1.ltta-10. Am J Respir Crit Care Med. 2000. PMID: 10673226 Review. No abstract available.
P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia.
Ballerini P, Di Iorio P, Ciccarelli R, Caciagli F, Poli A, Beraudi A, Buccella S, D'Alimonte I, D'Auro M, Nargi E, Patricelli P, Visini D, Traversa U. Ballerini P, et al. Int J Immunopathol Pharmacol. 2005 Apr-Jun;18(2):255-68. doi: 10.1177/039463200501800208. Int J Immunopathol Pharmacol. 2005. PMID: 15888248
Additional functions for the cysteinyl leukotrienes recognized through studies of inflammatory processes in null strains.
Austen KF. Austen KF. Prostaglandins Other Lipid Mediat. 2007 May;83(3):182-7. doi: 10.1016/j.prostaglandins.2007.01.004. Epub 2007 Jan 17. Prostaglandins Other Lipid Mediat. 2007. PMID: 17481553 Review.
Leukotriene signaling in atherosclerosis and ischemia.
Bäck M. Bäck M. Cardiovasc Drugs Ther. 2009 Feb;23(1):41-8. doi: 10.1007/s10557-008-6140-9. Epub 2008 Oct 24. Cardiovasc Drugs Ther. 2009. PMID: 18949546 Free PMC article. Review.

See all similar articles

Cited by

Pathogenesis of aspirin-exacerbated respiratory disease.
Stevenson DD, Zuraw BL. Stevenson DD, et al. Clin Rev Allergy Immunol. 2003 Apr;24(2):169-88. doi: 10.1385/CRIAI:24:2:169. Clin Rev Allergy Immunol. 2003. PMID: 12668897 Review.
The Kounis-Zavras syndrome with the Samter-Beer triad.
Schwartz BG, Daulat S, Kuiper J. Schwartz BG, et al. Proc (Bayl Univ Med Cent). 2011 Apr;24(2):107-9. doi: 10.1080/08998280.2011.11928695. Proc (Bayl Univ Med Cent). 2011. PMID: 21566756 Free PMC article.
Kounis syndrome induced by oral intake of aspirin: case report and literature review.
Hangouche AJE, Lamliki O, Oukerraj L, Dakka T, Doghmi N, Zarzur J, Cherti M. Hangouche AJE, et al. Pan Afr Med J. 2018 Aug 30;30:301. doi: 10.11604/pamj.2018.30.301.14948. eCollection 2018. Pan Afr Med J. 2018. PMID: 30637085 Free PMC article. Review.
Samter-Beer triad presenting as Kounis type I variant of syndrome.
Hamdi I, Chourabi C, Jabloun TY, Ghommidh M, Lahidheb D, Fehri W, Haouala H. Hamdi I, et al. J Saudi Heart Assoc. 2018 Jul;30(3):290-293. doi: 10.1016/j.jsha.2018.03.002. Epub 2018 Mar 24. J Saudi Heart Assoc. 2018. PMID: 29983505 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.